{
    "Case ID": "093486",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement and validity challenge"
    ],
    "Legal_Issue": [
        "Infringement of '505 and '186 patents; validity based on novelty and obviousness"
    ],
    "Governing_Law": [
        "Canadian Patent Act"
    ],
    "Procedural_Stage": [
        "Adjudication on merits"
    ],
    "Evidence_Assessment": [
        "Expert testimonies, prior art, claim construction"
    ],
    "Decision_Outcome": [
        "'505 patent valid but not infringed; '186 patent invalid for obviousness"
    ],
    "Burden_of_Proof": [
        "Claimant (Johnson & Johnson) bears burden for infringement; Defendant (Boston Scientific) bears burden for invalidity"
    ],
    "Credibility_Factor": [
        "Expert witness credibility assessed"
    ],
    "Legal_Rule": [
        "A patent is invalid if lacking novelty or obvious; infringement requires all essential elements to be present"
    ],
    "Standard_of_Review": [
        "Construction of patent claims: correctness; validity/infringement: mixed questions with deference to factual findings"
    ],
    "Procedural_Issue": [],
    "Grounds_for_Claim": [
        "Alleged infringement of '505 and '186 patents by NIR stent"
    ],
    "Outcome_on_Merits": [
        "Johnson & Johnson's claim fails; Boston Scientific's counterclaim succeeds in part"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [],
    "Review_Standard": [],
    "Procedural_Fairness_Assessment": [],
    "Key_Evidence_Considered": [
        "Structure of NIR stent, presence/absence of complete slots, prior art references suggesting connectors"
    ],
    "Legal_Framework": [
        "Patent law under Canadian Patent Act"
    ],
    "Applicant_Challenge": [
        "Johnson & Johnson challenged Boston Scientific's use of patented technology"
    ],
    "Court_Result": [
        "No infringement found; partial success for Boston Scientific on validity grounds"
    ],
    "Legal_Rule_Source": [
        "Canadian Patent Act"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Contested validity of both patents, particularly obviousness of '186 patent"
    ],
    "Evidence_Type": [
        "Documentary evidence, technical drawings, expert testimony"
    ],
    "Remedy_Requested": [
        "Injunction, damages for infringement"
    ],
    "Outcome": [
        "No remedy granted; '505 not infringed, '186 invalidated"
    ],
    "Decision_Authority": [
        "Trial Court"
    ],
    "Remedy_Sought": [
        "Enforcement of patent rights, exclusion of competing product"
    ],
    "Resolution_Mechanism": [
        "Judicial determination after trial"
    ],
    "Legal_Provision": [
        "Canadian Patent Act provisions on novelty, non-obviousness, and infringement"
    ],
    "Authority": [
        "Canadian courts"
    ],
    "Claimant_Status": [
        "Patent holder (Johnson & Johnson)"
    ],
    "Legal_Provision_Cited": [
        "Sections related to patent validity and infringement under Canadian Patent Act"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Obviousness of '186 patent based on prior art"
    ],
    "Applicable_Process": [
        "Civil litigation"
    ],
    "Outcome_of_Review": [],
    "Pending_Relief_or_Application": [],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Canadian Patent Act rules on patentability and infringement"
    ]
}